Language Is the Manifestation of Thought – Why Language Models Can Speak Without Thinking

Anyone who wants to know whether artificial intelligence thinks must first know what thinking actually is. That is precisely what is currently missing—in media reporting, in large parts of science, and among the makers of language models themselves. AI is credited with intelligence, understanding, learning, decision-making, or even empathy without first clarifying what these terms actually designate. A system that appears linguistically assured is credited with understanding; one that solves problems is deemed intelligent; and one that says “I” already seems to possess consciousness. Instead of determining the matter conceptually, people are dazzled by the impressive performance and infer an equally impressive machine mind.

Continue reading →

Die Sprache ist das Dasein des Denkens – Warum Sprachmodelle trotzdem nicht denken

Wer wissen will, ob Künstliche Intelligenz denkt, muss zunächst wissen, was Denken überhaupt ist. Genau daran fehlt es gegenwärtig – in der medialen Berichterstattung ebenso wie in weiten Teilen der Wissenschaft und bei den Herstellern der Sprachmodelle selbst. Man schreibt KI Intelligenz, Verstehen, Lernen, Entscheiden oder gar Empathie zu, ohne zuvor zu klären, was mit diesen Begriffen eigentlich bezeichnet ist. Wer sprachlich souverän erscheint, dem wird Verstehen zugeschrieben; wer Probleme löst, gilt als intelligent; und wer „ich“ sagt, scheint bereits ein Bewusstsein zu besitzen. Statt die Sache begrifflich zu bestimmen, ist man von der beeindruckenden Leistung geblendet und schließt auf einen ebenso beeindruckenden Maschinengeist.

Continue reading →

Much Ado About Personalized Medicine… or Why the Nose of Biomedical Research Keeps Growing Longer

The following article first appeared in German in the June 2025 issue of Laborjournal and was translated with the help of ChatGPT

Personalized medicine – or, as it prefers to be called these days, precision medicine (PM) – has been heralded for some time now as a kind of salvation. The great leap forward on the path to a healthier, more satisfying, and longer life. PM sounds so good, who could be against it? So convincing that it seemingly no longer needs any further proof that it represents something genuinely new – the golden road to the future of medicine.

Continue reading →

„Research Trek – Aufbruch in ein unbekanntes Wissenschaftssystem“

Für die Beitragsserie „Forschung vordenken für 2035“ in den table.briefings research skizzierte ich meine Vision für die wissenschaftspolitische Welt der Zukunft in Form der fiktiven TV-Serie „Research Trek“ – und lieferte die Rezension gleich mit.

Die biomedizinische Wissenschaft – grenzenlose Möglichkeiten. Wir schreiben das Jahr 2035. Dies sind die Abenteuer der akademischen Forschung, die mit ihrer interdisziplinären Crew aufbricht, die Geheimnisse des Lebens zu entschlüsseln – Krankheitsmechanismen zu verstehen, neue Diagnosen und Therapien zu entwickeln. Tief im Innersten des menschlichen Körpers und weit in den digitalen Raum hinein dringt sie vor – in molekulare Welten, die nie ein Mensch zuvor gesehen hat.

Continue reading →

AI in Medicine: Hubris, Hype, and Half-Science

Due to time constraints, I haven’t been able to maintain my blog since June 2023, which is why there haven’t been any new posts since then. However, the following article (published in Laborjournal 4/2023) fits very well with the last post, “Artificial Intelligence: Critique of Chatty Reasoning” and since I’ve received many requests for an English version, I asked ChatGPT (which, by the way, didn’t take offense at the content!) to provide a translation. The original German version can be found in Laborjournal.

AI has the potential to revolutionize medicine — but a reckless ‘move fast, break things’ mindset, industry lobbying, and glaring scientific gaps in transparency, validation, and bias control are getting in the way of building truly evidence-based AI.

Continue reading →

Fraud in science is rare. But is this actually true?

After a break of 2 years, here again an English translation of one of the musings of the ‚Wissenschaftsnarr‘ (i.e. ‚science jester‘) – my alter ego that writes a monthly column for the German periodical Laborjournal. My apologies, to save time I used DeepL, but the AI has some difficulty with the writing style of the science jester…

Wissenschaftsnarr # 53 (German version available here)


Almost weekly we read about cases of scientific misconduct. Often, renowned journals and prominent scientists play a role in them. The website Retractionwatch by Ivan Oranski and Adam Marcus provides us with such news and their backgrounds in an incessant stream. The Laborjournal, too, has a story in almost every issue about a lab where things were not going right. Most of the time, this came to light after an article with manipulated, falsified or even invented data was exposed. Whistleblowers or attentive readers who anonymously publish their doubts about the dignity of figures on PubPeer often bring this to the attention of the scientific public. Universities, funding agencies, or journals, on the other hand, conspicuously seldom uncover such malignant machinations.

Continue reading →

Boost your score: Digital narcissism in the competition of scientists

Do you have a fitness tracker? Are you on Twitter or Facebook and count your likes and followers? Do you know your ResearchGate score? Do you pay attention to Gault Millau toques and Michelin stars when you visit restaurants? Then you’re in good company, because you’re doing reputation management on a wide variety of levels with quantitative indicators. Just like universities and research sponsors. Except that you do it privately and entirely voluntarily!

On these pages I have recently discussed (here, and here) why in academia today we hardly judge research on the basis of its originality, quality and true scientific or societal impact. Instead, we use quantitative indicators such as Journal Impact Factor (JIF) or third-party funding, and distribute grants or academic titles based on these indicators. I also pondered a few foolish ideas on how to turn the wheel back a bit, in the direction of a content-based evaluation of research achievements. But these considerations still failed to take into account that institutions and funding agencies are in good company – namely ours – when they foster competition with simple, abstract metrics. This makes things easier for them. And at the same time, harder for us to change the system. Because we may have to change ourselves.

Continue reading →

In the fight against Corona, learning from Botswana means learning to win!

As long as the majority of the population is not immune to SARS-COV2, the health care system must be protected from collapse due to overload with COVID patients. Therefore, for the past year, we have been testing measures ranging from increased hand washing to total lockdown with some success. Measures are introduced, tightened, relaxed, or abolished, only to be reintroduced, … and so it goes. Politicians justify their actions with incidence values, utilization of hospitals, model calculations and the advice of experts (see also here in my blog). Undeniably, many of these (anti)Corona measures have enormous plausibility. It is also trivial to realize that a total lockdown can severely limit the spread of a virus. However, this cannot be sustained forever. Therefore, the question of which of the measures from the black box lockdown have an effect, and for which the harm outweighs the benefit, is immensely relevant. With this knowledge, one might put together an evidence-based package of Corona measures that is less drastic than a lockdown, but just as effective. And perhaps in this way persuade some skeptics to participate. This is why the question of which evidence is available for the effectiveness of individual measures is so important. But beware. Continue reading →

Judging science by proxies Part II: Back to the future

Science gobbles up massive amounts of societal resources, not just financial ones. For academic research in particular, which is self-governing and likes to invoke the freedom of research (which in Germany is even enshrined in the constitution), this raises the question of how it allocates the resources made available to it by society. There is no natural limit to how much research can be done – but there is certainly a limit to the resources that society can and will allocate to research. So which research should be funded, which scientists should be supported?

Mechanisms for answering these questions, which are central to the academic enterprise, have evolved evolutionarily over many decades. However, these mechanisms control not only the distribution of funds among researchers and within as well as between institutions, but ultimately also the content and quality of research. The mechanisms by which research funds and tenure are evaluated and allocated and the metrics used in these processes determine scientists’ daily routines and the way they do research more than their reading literature, their views through a microscope, or their presentations at conferences. Continue reading →

Jugdging science by proxies: A short and incomplete history

In this post I’ll be looking at the question of why scientific careers today depend so much on the Journal Impact Factor (JIF). And the acquisition of as much third-party funding as possible. Or, more generally, why the content, originality and reliability of research results are often a secondary matter when commissions talk their heads off about who to include in their own ranks. And who not. Or which grant applications deserve to be funded. In short, follow me on a brief and incomplete history of how and why we ended up judging the quality of science through proxies such as JIF and amount of third party funding. Perhaps a historical perspective will also yield clues as to how we can overcome this mess. But I am getting ahead of myself. Let’s start where it all began, with the founding fathers of modern science. Continue reading →